|
Medical Director Dr. Lehmann's specialties include bone marrow and stem cell transplantation and non-hodgkin's lymphoma. Dr. Lehmann's research is focused on the complications of bone marrow transplantation in cancer patients, neutrophil defenses in BMT patients, the metabolism and energy expenditure after BMT and novel methods to decrease induction regimen toxicity in BMT. She holds her academic appointment as Assistant Professor of Pediatrics at Harvard Medical School.
|
